Mostafa Abdelnasier Abdelgawad

Mostafa Abdelnasier Abdelgawad

Auto-generated profile, based on publicly available information

Mostafa Abdelnasier Abdelgawad

Department of Nephrology, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2022 in The Egyptian Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
MHMohamed Saeed Hassan
Mohamed Saeed Hassan
YAYasser Soliman Ahmed
Yasser Soliman Ahmed
ESEman Ibrahim Sarhaan
Eman Ibrahim Sarhaan
NMNayra Shaker Mehanna
Nayra Shaker Mehanna
NMNorhan Nagdy Madbouli
Norhan Nagdy Madbouli
MAMostafa Abdelnasier Abdelgawad
Mostafa Abdelnasier Abdelgawad
Background: Indoxyl sulfate (IS) is produced by action of the intestinal flora on tryptophan in protein diet, and it is normally excreted by the kidney. IS is a protein-bound uremic toxin, and it is difficult to be removed by conventional hemodialysis (HD) methods; so, it accumulates in HD patients and may contribute to major cardiovascular morbidity and mortality. Aim: To study the effect of dietary synbiotic (prebiotic and probiotic) supplementation on IS level in prevalent HD patients. Patients and methods: This single-blind, placebo-controlled trial was conducted on 80 prevalent HD patients (between January 2017 and March 2017) in Ain Shams University Hospital. Patients were divided into 2 groups: group 1 was given synbiotic (SYN) and group 2 was given placebo for 6 weeks. Blood levels of IS, CRP, creatinine, blood urea nitrogen (BUN), sodium, potassium, calcium, and phosphorus were measured at baseline and after 6 weeks. Results: There was a significant reduction in serum IS level in groups 1 and 2 in comparison to their baselines (P value = 0.000 and 0.019 respectively); however, the change in IS level in group 1 after SYN supplementation (64% with IR 72.38–33.33) was more than that shown in group 2 (did not receive SYN) (18.47% with IR 26.75–26.75) with a highly significant P value, 0.000. Also, there were significant reductions in the levels of creatinine, BUN, phosphorus (P values < 0.001), and CRP (P values 0.002) in group 1 respectively with no similar changes noticed in group 2. Conclusion: SYN supplementation in HD patients can reduce serum levels of IS and other uremic toxins like BUN and creatinine. Also, it may help to reduce serum phosphorus and CRP levels.

1 October 2020 in The Egyptian Journal of Hospital Medicine
Verified
Journal Article
Closed access
PDF file
ISIman Ibrahim Sarhan
Iman Ibrahim Sarhan
MAMohamed Mostafa Ali
Mohamed Mostafa Ali
AHAhmed Abd Elmonem Hassan
Ahmed Abd Elmonem Hassan
MEMostafa Abd Elnasier Abd Elgawad
Mostafa Abd Elnasier Abd Elgawad
Background: The frequency of hepatitis C virus (HCV) infection remains high in patients with CKD and plays a detrimental role in mortality in this population, and patients undergoing maintenance dialysis are still at risk of developing HCV infection and HCV disease prevalence of anti-hepatitis C virus (HCV) patients who undergo longterm dialysis are significantly greater than those with normal kidney function. Objectives: The aim of the study was to assess outcomes (efficacy, side effects, and possible complications) of DAADs for HCV in presence of CKD. Subjects and methods: this was retrospective cohort study that was conducted at Aswan Fever Hospital and Luxor Fever Hospital for anti HCV therapy between Jan 2018 and July 2018 including 60 patients recruited from both hospitals with all stages of CKD and were receiving DAADs. Results: the results revealed that PC (%) in patients from Aswan ranged between 61-100 with mean ±S.D. 83.09±9.258 while in patients from Luxor it ranged between 66-100 with mean ±S.D. 84.95±6.764. There was no statistically significant difference between groups (P=0.458). HCV PCR in all patients from Aswan at baseline were positive while after 3 months 27 (90%) were negative and 3 (10%) were positive and after 6 months all patients were negative while in patients from Luxor they all were positive while after 3 months 28 (93.3%) were negative and 2 (6.7%) were positive and after 6 months all patients were negative. There was no statistically significant difference between groups. Conclusion: Treatment with newer DAAs is effective and safe for the treatment of HCV-infected chronic kidney disease patients.

5 November 2025 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
MEMostafa Abdelnasier Abd Elgawad
Mostafa Abdelnasier Abd Elgawad
HSHowayda Abdelhamid El Shinnawy
Howayda Abdelhamid El Shinnawy
SESanaa Eissa
Sanaa Eissa
NANouran Abdelfattah Sayed Ali
Nouran Abdelfattah Sayed Ali
MBMaha Abdelmoneim Behairy
Maha Abdelmoneim Behairy
MKMarwa Kamel
Marwa Kamel
Background: Lupus nephritis (LN) represents a major complication in systemic lupus erythematosus (SLE). The objective of this study was to evaluate the TRIM8 gene and its associated non-coding RNAs ( lnc-SSBP2-1:1 and hsa-miR-126-5p ) as potential non-invasive biomarkers for LN activity. Methods: Bioinformatics analyses were initially employed to identify candidate mRNA and associated non-coding RNAs (ncRNAs) implicated in LN. Expression profiles of TRIM8lnc-SSBP2-1:1 and hsa-miR-126-5p were validated in blood samples from 40 active LN, 30 inactive LN patients, and 20 healthy individuals via real-time PCR. Results: TRIM8 mRNA and lnc-SSBP2-1:1 lncRNA levels were notably upregulated in active LN ( p < 0.001), while hsa-miR-126-5p was reduced ( p < 0.001). SLEDAI-2K scores correlated positively with TRIM8 mRNA and lnc-SSBP2-1:1 , and negatively with hsa-miR-126-5p . Conclusions: This study highlights TRIM8 -associated ncRNA regulatory network as promising biomarkers in LN activωity, with potential clinical impact. Graphical

2 April 2026 in Journal of The Egyptian Society of Nephrology and Transplantation
Verified
Journal Article
Open access
MAMostafa A. Abdelgawad
Mostafa A. Abdelgawad
HEHaitham A. Ezzat
Haitham A. Ezzat
NENourhan M. Hossam Eldin
Nourhan M. Hossam Eldin
HNHala G.M. Noweir
Hala G.M. Noweir
LKLamis E. Khedr
Lamis E. Khedr
Background: Arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis, but its maturation and long-term function are often suboptimal. Preoperative handgrip exercise (HGE) may improve vascular remodeling and enhance outcomes of AVF. This study aimed to evaluate the effect of preoperative handgrip training on vein diameter (VD) and AVF functional performance in patients with chronic kidney disease (CKD). Patients and methods: This was a single-center, prospective pilot study including 40 patients with advanced CKD eligible for AVF creation. Candidates were allocated into an exercise group ( n =20), who performed daily HGEs for 8 weeks prior to surgery, and a control group ( n =20), who received standard care without exercise. VDs at the cubital and wrist levels were measured by Doppler ultrasound at baseline, after 8 weeks, and 6 weeks post-AVF creation. AVF maturation and functional performance were assessed by postoperative blood flow and site distribution. Subgroup analysis was performed in patients with diabetes. Results: Baseline demographic and clinical characteristics were comparable between groups. After 8 weeks, the exercise group showed significantly greater increases in VD at both the cubital and wrist sites compared with the control group. Postoperatively, the exercise group maintained larger venous diameters (cubital: 6.96 ± 0.17 vs. 6.00 ± 0.13 mm, P <0.00001; wrist: 7.10 ± 0.46 vs. 6.00 ± 0.07 mm, P <0.0001). AVF blood flow (Qa) was higher in the exercise group (915 ± 117 vs. 635 ± 37 ml/min, P <0.0001), and distal fistulas were more common (75 vs. 20%, P =0.03). Among diabetic patients, exercise was associated with significantly larger postoperative VDs and higher blood flow compared with the control group. Conclusions: Preoperative HGE is a simple, low-cost intervention that enhances venous dilatation, improves AVF blood flow, and favors distal AVF creation in patients with CKD. These findings support the incorporation of structured exercise into preoperative care to optimize vascular access outcomes. Larger, multicenter studies are warranted to confirm these results.

1 October 2024 in QJM: An International Journal of Medicine
Verified
Journal Article
Closed access
PDF file
HEHowaida Abdelhamid Elshinnawy
Howaida Abdelhamid Elshinnawy
HEHisham Mohamed Elsayed
Hisham Mohamed Elsayed
HHHayam Ahmed Hebah
Hayam Ahmed Hebah
WAWaleed Anwar Abdelmohsen
Waleed Anwar Abdelmohsen
DFDina Abou-Bakr Farrag
Dina Abou-Bakr Farrag
MAMostafa Abdelnasier Abdelgawad
Mostafa Abdelnasier Abdelgawad
Background: Hemodialysis is an indispensable therapeutic intervention for patients with end-stage renal disease (ESRD). However, it has certain limitations in managing the reduction in physical functionality and cardiovascular fitness. On the other hand, intradialytic exercise has demonstrated potential in enhancing health-related quality of life (HRQOL) and cardiopulmonary fitness in patients with chronic kidney disease who are undergoing maintenance hemodialysis. Aim of the Work: This study aimed to investigate the impact of intra-dialytic exercise on the efficiency of hemodialysis sessions, the clearance of various solutes, and solute rebound in patients with ESRD receiving regular hemodialysis. Patients and Methods: The study included forty adult ESRD patients undergoing regular hemodialysis, divided into two groups: Group 1 (intra-dialytic exercise program) and Group 2 (no intra-dialytic exercise program). Clinical characteristics were matched between the groups to ensure unbiased findings. Results: The intra-dialytic exercise group showed significantly lower blood urea nitrogen levels and higher urea reduction ratio (URR%) compared to the control group. Equilibrated Kt/V (eKt/V) values were also higher in the exercise group, suggesting more efficient dialysis treatment. In terms of minerals, the exercise group had reduced phosphorus levels and higher phosphorus reduction rate (Po4 RR%) compared to the control group. However, no significant difference was found in potassium levels between the groups. Conclusion: The findings support previous research on the positive effects of intra-dialytic exercise on dialysis efficacy and electrolyte management. Intra-dialytic exercise may enhance waste product clearance and improve overall health outcomes in ESRD patients.